Your browser doesn't support javascript.
loading
Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations.
Mora-Jimenez, Lucia; Valencia, Miguel; Sanchez-Carpintero, Rocio; Tønnesen, Jan; Fadila, Saja; Rubinstein, Moran; Gonzalez-Aparicio, Manuela; Bunuales, Maria; Fernandez-Pierola, Eva; Nicolas, Maria Jesus; Puerta, Elena; Miguelez, Cristina; Minguez, Paula Gimenez; Lumbreras, Sara; Gonzalez-Aseguinolaza, Gloria; Ricobaraza, Ana; Hernandez-Alcoceba, Ruben.
Afiliación
  • Mora-Jimenez L; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Valencia M; Neuroscience Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Sanchez-Carpintero R; University Clinic of Navarra, Dravet Syndrome Unit, Pediatric Neurology Unit, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Tønnesen J; Achucarro Basque Center for Neuroscience and Department of Neuroscience, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Fadila S; Goldschleger Eye Research Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rubinstein M; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gonzalez-Aparicio M; Goldschleger Eye Research Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bunuales M; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Fernandez-Pierola E; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Nicolas MJ; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Puerta E; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Miguelez C; Gene Therapy and Regulation of Gene Expression Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Minguez PG; University Clinic of Navarra, Dravet Syndrome Unit, Pediatric Neurology Unit, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Lumbreras S; Neuroscience Program, CIMA, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Gonzalez-Aseguinolaza G; Department of Pharmacology and Toxicology, University of Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Ricobaraza A; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Hernandez-Alcoceba R; Autonomic and Movement Disorders Unit, Neurodegenerative Diseases, Biocruces Health Research Institute, Barakaldo, Spain.
Mol Ther Nucleic Acids ; 25: 585-602, 2021 Sep 03.
Article en En | MEDLINE | ID: mdl-34589280
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2021 Tipo del documento: Article País de afiliación: España